- Home
- XRPNW vs LFMDP Comparison
XRPNW vs LFMDP Comparison
Compare XRPNW & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XRPNW | LFMDP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 2 | 384 |
| Industry | Blank Checks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | XRPNW | LFMDP |
|---|---|---|
| Price | $0.59 | $23.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 37.7K | 1.6K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.56 | $18.50 |
| 52 Week High | $1.20 | $25.25 |
Technical Indicators
Market Signals| Indicator | XRPNW | LFMDP |
|---|---|---|
| Relative Strength Index (RSI) | 35.15 | 68.93 |
| Support Level | N/A | $23.95 |
| Resistance Level | $0.82 | $24.19 |
| Average True Range (ATR) | 0.05 | 0.31 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 8.33 | 100.00 |
Price Performance
Historical ComparisonAbout XRPNW Armada Acquisition Corp. II Warrant
Armada Acquisition Corp II is a blank check company.
About LFMDP LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.